Proximagen Neuroscience


Proximagen is researching and developing treatments for neurodegenerative diseases. It is working on four main groups of compounds. PRX1 is for Parkinson's disease, PRX2 is for the treatment of dyskinesia or involuntary movements, PRX4 is for neuroprotection of human nerve cells and PRX5 is designed to reduce cognitive decline.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds